Browse > Article
http://dx.doi.org/10.7314/APJCP.2015.16.16.6877

Protective Role of Selenium and High Dose Vitamin E against Cisplatin - Induced Nephrotoxicty in Rats  

Aksoy, Asude (Department of Medical Oncology, Medical Faculty, Firat University)
Karaoglu, Aziz (Department of Medical Oncology, Medical Faculty, Dokuz Eylul University)
Akpolat, Nusret (Department of Pathology, Medical Faculty, Inonu University)
Naziroglu, Mustafa (Department of Biophysics, Medical Faculty, Suleyman Demirel University)
Ozturk, Turkan (Department of Medical Oncology, Medical Faculty, Karadeniz Teknik University)
Karagoz, Zuhal Karaca (Department of Internal Medicine-Endocrinology, Elazig Regional Education and Research Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.16, no.16, 2015 , pp. 6877-6882 More about this Journal
Abstract
Background: Cisplatin (CDDP) is one of the most active cytotoxic agents in the treatment of cancer. We investigated the effect of selenium (Se) with high dose vitamin E (VE) administration to prevent CDDP-induced nephrotoxicity in rats. Materials and Methods: In this study, 40 female Wistar rats were randomly divided into five equal groups. The first group, which served as the control, was administered physiological saline (2.5 cc/day, 5 days) intraperitoneally (IP), while group A was administered cisplatin (6 mg/kg BW/ single dose) plus physiological saline IP. Groups B, C, D received IP five doses of Se (1.5 mg/kg BW), and a high dose of VE (1000 mg/kg BW) (Se-VE) in combination before, simultaneously, and after CDDP, respectively. The rats were sacrificed five days after CDDP administration. Plasma malondialdehide (MDA), glutathione peroxidase (GSH-Px), reduced glutathione (GSH), catalase, urea, creatinine levels, renal histopathological changes were measured. Results: The histopathological injury score, plasma levels of MDA, urea, creatinine were found to increase in group A compared to the control (p<0.05), while plasma levels of GSH-Px, GSH and catalase decreased (p<0.05). In contrast, plasma levels of MDA decreased (p<0.05) in groups B, C, D, which were treated with Se- VE, whereas levels of GSH-Px, GSH were found to increase only for group D (p<0.05). Plasma urea, creatinine levels improved in the treatment groups compared to group A (p<0.001). Histopathological changes caused by CDDP were also significantly improved after Se-VE treatment (p<0.05). Conclusions: Oxidative stress increases with CDDP-induced nephrotoxicity in rats. Se-VE supplementation might thus play a role in the prevention of CDDP-induced nephrotoxicity in patients.
Keywords
Cisplatin-induced nephropathy; oxidative stress; vitamin E; selenium;
Citations & Related Records
Times Cited By KSCI : 6  (Citation Analysis)
연도 인용수 순위
1 Abdel Moneim AE, Othman MS (2014). Azadirachta indica attenuates cisplatin-induced nephrotoxicity and oxidative stress. Biomed Res Int, 647131.
2 Aebi H (1983). Methods in enzymatic analysis. in catalase, bergmeyer HU (Ed.), academic press, New York, 3, 276-86.
3 Antunes LM, Darin JD, Bianchi N de L. (2001). Effects of the antioxidants curcumin or selenium on cisplatin-induced nephrotoxicity and lipid peroxidation in rats. Pharmacol Res Feb, 43, 145-150.   DOI
4 Arsenyan P, Paegle E, Domracheva I, Gulbe A, Kanepe-Lapsa I (2014). Shestakova i. selenium analogues of raloxifene as promising antiproliferative agents in treatment of breast cancer. Eur J Med Chem, 87, 471- 83.   DOI
5 Arunkumar PA, Viswanatha GL, Radheshyam N, et al (2012). Science behind cisplatin-induced nephrotoxicity in humans: a clinical study. Asian Pac J Trop Biomed, 2, 640- 44.   DOI
6 Atessahin A, Yilmaz S, Karahan I, et al (2005). Effects of lycopene against cisplatin-induced nephrotoxicity and oxidative stress in rats. Toxicol, 212, 116-23.   DOI
7 Brigelius-Flohe R, Kipp A (2009). Glutathione peroxidases in different stages of carcinogenesis. Biochim Biophys Acta, 1790, 1555- 68.   DOI
8 Chirino, YI, Hernandez-Pando R, Pedraza-Chaverri J (2004). Peroxynitrite decomposition catalyst ameliorates renal damage and protein nitration in cisplatin-induced nephrotoxicity in rats. BMC Pharmacol, 4, 20-29.   DOI
9 Dimri K, Pandey AK, Trehan R, et al (2013). Conventional radiotherapy with concurrent weekly Cisplatin in locally advanced head and neck cancers of squamous cell origin-a single institution experience. Asian Pac J Cancer Prev, 14, 6883-88.   DOI
10 Erten C, Demir L, Somali I, et al (2013). Cisplatin plus gemcitabine for treatment of breast cancer patients with brain metastases; a preferential option for triple negative patients? Asian Pac J Cancer Prev, 14, 3711-17.   DOI
11 Ferlay J, Soerjomataram I, Dikshit R, et al (2014). Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, 136, 359-86.
12 Jones DP, Radi R (2014). Redox pioneer: professor helmut sies. Antioxid Redox Signal, 21, 2459-68   DOI
13 Fuertes MA, Castilla J, Alanso C, et al (2002). Novel concepts in the development of platinum antitumor drugs. Current Medicinal Chemistry- Anticancer Agents, 2, 539-51.   DOI
14 Jerome-Morais A, Wright ME, Liu R, Yang W, et al (2012). Inverse association between glutathione peroxidase activity and both selenium-binding protein 1 levels and Gleason score in human prostate tissue. Prostate, 72, 1006-12   DOI
15 Ji J, Liu J, Liu H, Wang Y (2014). Effects of fermented mushroom of cordyceps sinensis, rich in selenium, on uterine cervix cancer. Evid Based Complement Alternat Med, 2014, 173180.
16 Ghorbani A, Omidvar B, Parsi A (2013). Protective effect of selenium on cisplatin induced nephrotoxicity: A double blind controlled randomized clinical trial. J Nephropathol, 2, 129-34.   DOI
17 Gupta RK, Singh N (2013). Morinda citrifolia (Noni) alters oxidative stress marker and antioxidant activity in cervical cancer cell lines. Asian Pac J Cancer Prev, 14, 4603-6.   DOI
18 Gurocak S, Karabulut E, Karadag N, et al (2013). Preventive effects of resveratrol against azoxymethane induced damage in rat liver. Asian Pac J Cancer Prev, 14, 2367-70.   DOI
19 Ha YS, Lee GT, Kim Y H, et al (2014). Decreased seleniumbinding protein 1 mRNA expression is associated with poor prognosis in renal cell carcinoma. World J Surg Onco, 12, 288.   DOI
20 Wang J, Liu F, Huang DX, et al (2012). Post-operative treatment with cisplatin and vinorelbine in Chinese patients with nonsmall cell lung cancer: a clinical prospective analysis of 451 patients. Asian Pac J Cancer Prev, 13, 4505-10.   DOI
21 Ohkawa H, Ohishi N, Yagi K (1979). Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem, 95, 351-58.   DOI
22 Kappus H, Diplock AT (1992).Tolerance and safety of vitamine E: a toxicological position report. Free Rad Biol Med, 13, 55-74.   DOI
23 Lawrence RA, Burk RF (1976). Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun, 71, 952-58.   DOI
24 Martinis BS, Bianchi M de P (2001). Effect of vitamin c supplementation against cisplatin-induced toxicity and oxidative DNA damage in rats. Pharmacol Res, 44, 317-20.   DOI
25 Sedlak J, Lindsay RHC (1968). Estimation of total, protein bound and non-protein sulfhydryl groups in tissue with Ellmann’s reagent. Anal Biochem, 25, 192-05.   DOI
26 Tabacco A, Meiattini F, Moda E, et al (1979). Simplified enzymic/colorimetric serum urea nitrogen determination. Clinical Chemistry, 25, 336-37.
27 Weijl NI, Elsendoorn, TJ, Lentjes, EG, et al (2004). Supplementation with antioxidant micronutrients and chemotherapy-induced toxicity in cancer patients treated with cisplatin-based hemotherapy: a randomised, double blind, placebo-controlled study. Eur J Cancer, 40, 1713-23.   DOI
28 Ueda T, Mihara Y, Yoshimina K (1986). Mechanism of cisplatinium neprotoxicity. Jpn J Nephrol, 28, 940-42.
29 Yokozawa T, Liu ZW (2000).The role of ginsenoside-Rd in cisplatin-induced acute renal failure. Ren Fail, 22, 115-27.   DOI
30 Zhao JA, Peng L, Geng CZ, et al (2014). Preventive effect of hydrazine curcumin on carcinogenesis of diethyl nitrosamine-induced hepatocarcinoma in male SD rats. Asian Pac J Cancer Prev, 15, 2115-21.   DOI
31 Zhuo P, Diamond AM (2009). Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim Biophys Acta, 1790, 1546-54.   DOI